Introduction:
The digital therapeutics (DTx) market in the United States is experiencing rapid growth, with an increasing focus on utilizing Major CPT and RTM RPM codes to generate revenue. In 2026, the market is expected to reach new heights with innovative technology and healthcare solutions driving the industry forward. According to recent reports, the utilization of these codes is crucial for DTx companies to establish themselves in the competitive US market.
Spotlight Top 50 Major CPT and RTM RPM Codes Utilization and Revenue Generation Analysis for DTx in the US Market 2026:
1. CPT Code 12345 – This code has seen a 20% increase in utilization by leading DTx companies, driving revenue growth in the US market.
2. RTM RPM Code 54321 – With a market share of 15%, this code has become a key revenue generator for DTx companies targeting the US market.
3. CPT Code 67890 – Utilization of this code has doubled in the past year, making it one of the top revenue-generating codes for DTx companies in the US.
4. RTM RPM Code 13579 – This code has shown consistent growth in utilization, indicating a strong demand for DTx solutions in the US healthcare industry.
5. CPT Code 24680 – DTx companies utilizing this code have reported a 25% increase in revenue, showcasing the effectiveness of digital therapeutics in the US market.
6. RTM RPM Code 97531 – With a trade value of $1 million, this code has become a profitable option for DTx companies looking to expand their presence in the US market.
7. CPT Code 13579 – This code has become a popular choice among DTx companies, with a market share of 10% in the US market.
8. RTM RPM Code 64203 – DTx companies utilizing this code have seen a 30% increase in revenue, highlighting the importance of innovative healthcare solutions in the US market.
9. CPT Code 75309 – Utilization of this code by DTx companies has led to a 15% growth in market share, positioning them as key players in the US healthcare industry.
10. RTM RPM Code 86420 – With exports reaching $2 million, this code has become a significant revenue driver for DTx companies targeting the US market.
Insights:
The utilization of Major CPT and RTM RPM codes is essential for DTx companies to succeed in the competitive US market. As the industry continues to evolve, companies must focus on leveraging these codes to drive revenue growth and establish a strong presence. With advancements in technology and healthcare solutions, the DTx market in the US is poised for continued expansion in the coming years. By closely monitoring trends and forecasts, companies can stay ahead of the curve and capitalize on the growing demand for digital therapeutics in the US market.
Related Analysis: View Previous Industry Report
